CA
BLU

Corriente Advisors’s BELLUS Health Inc. BLU Stock Holding History

Corriente Advisors’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-148,666
Closed -$1.48M – 19
2020
Q1 		$1.48M Sell
148,666
-71,334
-32% -$636K 1.6% 9
2019
Q4 		$1.67M Buy
+220,000
New +$1.5M 0.9% 16

Other funds holding BLU

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Corriente Advisors's BLU Position: Q2 2020 in Review

Corriente Advisors sold out of BELLUS Health Inc. (BLU) in Q2 2020, closing a stake of 148,666 shares — an estimated $1.48M sold.

Corriente Advisors first reported a position in BLU in Q4 2019 and held it in 2 quarters. The position peaked at $1.67M in Q4 2019. 64 funds tracked by Wall St. Rank hold BLU as of Q2 2020.

  • Corriente Advisors reported no remaining BELLUS Health Inc. position as of Q2 2020 after selling out during the quarter.
  • Corriente Advisors sold 148,666 BELLUS Health Inc. shares in Q2 2020, an estimated $1.48M.
  • Corriente Advisors first reported a position in BELLUS Health Inc. in Q4 2019 and held it in 2 quarters.
  • Corriente Advisors's BELLUS Health Inc. position peaked at $1.67M in Q4 2019.
  • 64 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2020.

Based on Corriente Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.